At the end of 2019, an outbreak of a new Coronavirus 2019 (COVID-19) emerged in Wuhan in China, being called the causative agent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], [2].
According to the World Health Organization, more than 5 million people are infected in 216 countries and more than 331 thousand people died from COVID-19 [5].
The frequent and persistent clinical manifestations of anosmia / dysgeusia is present in patients with COVID-19, and neurological symptoms are also reported in severe cases, which may be secondary to severe respiratory failure [24].
One study showed that a patient with SARS-CoV-2 infection and encephalitis had a severe increase in inflammatory cytokines in the CSF, such as Interleukin-8, TNF-Î±, a finding that demonstrates the inflammatory involvement in neurological repercussions related to COVID-19 [28].
At the end of 2019, there was an outbreak of a new Coronavirus 2019 (COVID-19 disease).